T40.994 Poisoning by other psychodysleptics [hallucinogens], undetermined

Name of the Condition

• Poisoning by other psychodysleptics [hallucinogens], undetermined

Summary

This ICD code applies to cases of poisoning by other psychodysleptics (hallucinogens) where the intent—whether accidental, intentional self-harm, or undetermined—cannot be established. It covers toxic effects from substances that alter perception, mood, or consciousness, such as mescaline, DMT, or other hallucinogens not classified elsewhere. The code is used when clinical or contextual information is insufficient to determine the cause of exposure.

Causes

Poisoning may result from exposure to hallucinogens through ingestion, inhalation, or other routes. The lack of intent determination suggests scenarios where the circumstances of exposure are unclear, such as unknown ingestion, ambiguous self-administration, or unexplained environmental exposure. Interactions with other substances may also contribute to toxicity.

Risk Factors

• History of substance use or experimentation.
• Access to hallucinogens in unsecured environments.
• Concurrent use of other psychoactive substances.
• Cognitive impairments affecting judgment or safety awareness.
• Lack of supervision or support for medication adherence.

Symptoms

• Hallucinations, altered perception, or sensory distortions.
• Anxiety, paranoia, or disorientation.
• Nausea, vomiting, or dizziness.
• Increased heart rate or blood pressure.
• Potential for severe psychological distress or confusion.

Diagnosis

Diagnosis involves clinical evaluation of symptoms, toxicology screening for hallucinogens, and assessment of the circumstances of exposure. Medical history, including substance use or environmental factors, is critical. When intent cannot be determined, documentation should reflect the ambiguity of the exposure context.

Treatment Options

Treatment focuses on stabilizing the patient, managing acute symptoms (e.g., agitation, cardiovascular effects), and providing supportive care. Interventions may include monitoring vital signs, administering medications to address specific symptoms, and ensuring a safe environment. In cases of undetermined intent, psychosocial assessment may be warranted.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, underlying health, and timely intervention. Most cases resolve with appropriate care, but psychological effects (e.g., prolonged anxiety or psychosis) may persist. Follow-up may include monitoring for delayed symptoms or referral to mental health services if needed.

Complications

• Severe psychological distress or psychosis.
• Cardiovascular instability (e.g., hypertension, tachycardia).
• Respiratory depression or other systemic effects.
• Long-term cognitive or perceptual changes.

Lifestyle & Prevention

• Secure storage of substances to prevent accidental exposure.
• Education on the risks of hallucinogen use.
• Avoidance of mixing substances to reduce toxicity risk.
• Support for individuals with substance use concerns.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning occur, such as altered perception, severe anxiety, or physical distress. Professional help is also recommended for ongoing psychological effects or if substance use is a concern.

Tips for Medical Coders

Document the clinical rationale for using this code, including the inability to determine intent (e.g., unclear history, insufficient context). Ensure supporting documentation reflects the ambiguity of exposure circumstances. This code is appropriate when intent cannot be classified as accidental, intentional self-harm, or assault.